ASTRALS · CVHB937B12201

Public neurological clinical research study information. Check the current recruitment status in the live Wix study record.

A 40-week phase 2 placebo-controlled study of VHB937 in amyotrophic lateral sclerosis (ALS), followed by an open-label extension.

Sponsor: NOVARTIS

Phase: II

Area: Neuromuscular disorders